Clinical Trial Update: A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers [Phase 2]

View source ↗

Summary

Phase 2 study update evaluating the pharmacokinetic profile of CBL-514 injection in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subcutaneous Fat

Drugs mentioned

• CBL-514

Snippet

Sponsor: Caliway Biopharmaceuticals Co., Ltd. | Conditions: Subcutaneous Fat | Phase 2 | Status: COMPLETED